Published in Fam Cancer on January 01, 2005
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet (2006) 4.23
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet (2009) 3.99
Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet (2008) 1.81
Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term. World J Gastroenterol (2006) 1.70
The role of DNA damage repair in aging of adult stem cells. Nucleic Acids Res (2007) 1.35
A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene. Blood (2008) 1.12
Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutation. Haematologica (2009) 1.01
Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families. Mutat Res (2009) 1.00
Hereditary cancer-associated missense mutations in hMSH6 uncouple ATP hydrolysis from DNA mismatch binding. J Biol Chem (2008) 0.93
Application of molecular diagnostics for the detection of Lynch syndrome. Expert Rev Mol Diagn (2010) 0.89
Anticipation in lynch syndrome: where we are where we go. Curr Genomics (2011) 0.87
Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis. Blood (2012) 0.86
Genetic predispositions to childhood leukemia. Ther Adv Hematol (2013) 0.82
Identifying cross-category relations in gene ontology and constructing genome-specific term association networks. BMC Bioinformatics (2013) 0.82
Msh6 protects mature B cells from lymphoma by preserving genomic stability. Am J Pathol (2010) 0.80
Inherited colorectal cancer syndromes. Clin Colon Rectal Surg (2009) 0.79
Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses. Genet Med (2016) 0.77
Three independent mutations in the TSC2 gene in a family with tuberous sclerosis. Eur J Hum Genet (2009) 0.76
Non-Hodgkin lymphoma risk and variants in genes controlling lymphocyte development. PLoS One (2013) 0.75
Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis. BMC Cancer (2010) 0.75
Novel Implications in Molecular Diagnosis of Lynch Syndrome. Gastroenterol Res Pract (2017) 0.75
MSI detection and its pitfalls in CMMRD syndrome in a family with a bi-allelic MLH1 mutation. Fam Cancer (2016) 0.75
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65
A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst (1997) 5.68
Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell (1995) 5.54
Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell (1995) 3.34
AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology (2001) 2.63
Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst (1995) 2.62
Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Cell (1997) 2.46
Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet (1998) 2.32
Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology (2001) 1.78
Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res (1999) 1.62
Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet (2004) 1.58
Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res (1999) 1.50
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer (1985) 1.48
Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res (1996) 1.34
Clinical diagnosis and management of hereditary colorectal cancer syndromes. J Clin Oncol (2000) 1.32
A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple café-au-lait spots. Cancer Res (2002) 1.23
Extensive somatic microsatellite mutations in normal human tissue. Cancer Res (2001) 1.22
Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene. Oncogene (2000) 1.19
Drastic genetic instability of tumors and normal tissues in Turcot syndrome. Oncogene (1997) 1.13
Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC? Fam Cancer (2001) 1.06
Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology (2004) 1.05
Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Hum Genet (2002) 1.03
A homozygous MSH6 mutation in a child with café-au-lait spots, oligodendroglioma and rectal cancer. Fam Cancer (2004) 1.00
HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1. Genes Chromosomes Cancer (2004) 1.00
Early onset brain tumor and lymphoma in MSH2-deficient children. Am J Hum Genet (2003) 0.96
The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation. Am J Gastroenterol (1998) 0.88
Clinical features and pathobiology of neurofibromatosis 1. J Child Neurol (2002) 0.88
The Muir-Torre syndrome in kindreds with hereditary nonpolyposis colorectal cancer (Lynch syndrome): A classic obligation in preventive medicine. J Am Acad Dermatol (1999) 0.87
Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT. Oncogene (1999) 0.80
Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. Oncogene (2003) 0.80
Transgenic expression of human MGMT blocks the hypersensitivity of PMS2-deficient mice to low dose MNU thymic lymphomagenesis. Carcinogenesis (1999) 0.79
Hereditary nonpolyposis colorectal cancer: a call for attention. J Clin Oncol (2000) 0.78
The hPMS2 exon 5 mutation and malignant glioma. Case report. J Neurosurg (1999) 0.75